SECOND AMENDMENT TO AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • February 25th, 2020 • Theratechnologies Inc. • Pharmaceutical preparations
This Second Amendment to Amended and Restated Master Services Agreement (this “Amendment 2”) dated February 3, 2020 (the “Amendment 2 Effective Date”) is made by and between inVentiv Commercial Services, LLC, a Syneos Health™ group company with an office located at 500 Atrium Drive, Somerset, NJ 08873 (“Syneos Health”) and Theratechnologies Inc., a Canadian corporation with offices located at 2015 Peel Street, 11th Floor, Montreal, Quebec, Canada H3A 1T8 (“Client”). Client and Syneos Health may each be referred to herein as a “Party” and collectively, the “Parties”.
MASTER SERVICES AGREEMENTMaster Services Agreement • February 25th, 2020 • Theratechnologies Inc. • Pharmaceutical preparations • New Jersey
This Master Services Agreement (“Agreement”) is made as of this 15th day of July, 2019 (the “Effective Date”) by and between Asembia LLC, a limited liability corporation incorporated under the laws of the State of Delaware having an address of 200 Park Avenue, Suite 300, Florham Park, New Jersey 07932, its affiliate under common majority control and ownership ASPN Pharmacies, LLC (collectively, “Provider”) and Theratechnologies Inc., a corporation governed by the Business Corporations Act (Québec) having an address of 2015 Peel, Suite 1100, Montreal, Québec H3A 1T8, including any and all affiliates (“Company”). Provider and Company may be referred to in this Agreement individually as a “Party” or collectively as the “Parties”.
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • February 25th, 2020 • Theratechnologies Inc. • Pharmaceutical preparations • New York
This Amended and Restated License Agreement (“A&R Agreement”) is made as of the 3rd day of February, 2020 (“Effective Date”), between Theratechnologies Inc., a Québec company, having a principal place of business at 2015 Peel Street, 11th Floor, in the City of Montréal, Province of Québec, H3A 1T8, Canada (“Company”) and The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 (“Institution”), each referred to herein individually as a (“Party”) and, collectively, as the (“Parties”).
